Some flavonoid compounds, such as catechins, isoliquiritigenin, galangin, and luteolin, exhibit anti-inflammatory and antioxidant properties, potentially mediated through the Nrf2 signaling pathway, offering potential for the treatment of DCM [252,253,259,260]. This evidence concerns the gene NFE2L2 and familial dilated cardiomyopathy.